Neutropenic enterocolitis in patients after high dose chemotherapy and autologous stem cell transplantation - Risk factors analysis and outcome

被引：0
|
作者：
Gil, L. [1 ]
Nowicki, A. [1 ]
Poplawski, D. [1 ]
Mol, A. [1 ]
Czyz, A. [1 ]
Lojko-Dankowska, A. [1 ]
Matuszak, M. [1 ]
Dytfeld, D. [1 ]
Komarnicki, M. [1 ]
机构：
[1] Univ Med Sci, Poznan, Poland
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [1] Neutropenic enterocolitis after high-dose chemotherapy and autologous stem cell transplantation: incidence, risk factors, and outcome
    Gil, L.
    Poplawski, D.
    Mol, A.
    Nowicki, A.
    Schneider, A.
    Komarnicki, M.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (01) : 1 - 7
  • [2] Neutropenic enterocolitis incidence after autologous stem cell transplantation
    Ozsoy, E.
    Soyer, N.
    Tobu, M.
    Sahin, F.
    Saydam, G.
    Tombuloglu, M.
    Vural, F.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S259 - S259
  • [3] Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: Risk factors analysis and outcome
    Gil, L.
    Styczynski, J.
    Komarnicki, M.
    [J]. INFECTION, 2007, 35 (06) : 421 - 427
  • [4] Infectious Complication in 314 Patients after High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation: Risk Factors Analysis and Outcome
    L. Gil
    J. Styczynski
    M. Komarnicki
    [J]. Infection, 2007, 35 : 421 - 427
  • [5] Incidence and Risk Factors of Neutropenic Enterocolitis after Myelosuppressive Chemotherapy
    Seydoux, C.
    Brunel, A-S.
    Ahlyege, S.
    Cairoli, A.
    Spertini, O.
    Marchetti, O.
    Gavillet, M.
    Bochud, P. -Y.
    [J]. SWISS MEDICAL WEEKLY, 2022, 152 : 39S - 39S
  • [6] Toxicity and Outcome following High Dose Chemotherapy and Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma
    Lemieux, Christopher
    Laroche, Vincent
    Cantin, Guy
    Cote, Julie
    Demers, Christine
    Gallagher, Genevieve
    [J]. BONE MARROW TRANSPLANTATION, 2018, 53 : 658 - 659
  • [7] Aspergillosis after high-dose chemotherapy and autologous stem cell transplantation.
    Fetscher, S
    Technau, K
    Lange, W
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 : S114 - S114
  • [8] Single agent cefepime as empiric therapy for neutropenic fever after high-dose chemotherapy and autologous stem cell transplantation.
    Caldera, H
    Rabassa, C
    Albrecht, F
    Goodman, MS
    Fernandez, HF
    [J]. BLOOD, 2001, 98 (11) : 354B - 354B
  • [9] Stem cell dose and tumorbiologic parameters are predictors for outcome after high-dose chemotherapy with autologous blood stem cell transplantation in patients with metastatic breast cancer.
    Hensel, M
    Schneeweiss, A
    Sinn, HP
    Egerer, G
    Kornacker, M
    Solomayer, E
    Bastert, G
    Ho, AD
    [J]. BLOOD, 2001, 98 (11) : 692A - 692A
  • [10] HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA: WHAT PREDICTS THE OUTCOME?
    Kumar, L.
    Ganess, P.
    Gogia, A.
    Ghosh, I.
    Hariprasad, R.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S239 - S240
12345